ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1027

Characterization of Antibody Secreting Cells in Patients with Active Systemic Lupus Erythematosus

Weirong Chen1, Sohee Hong 2, Christopher Tipton 1, Jennifer Hom 1, Fabliha Anam 3, Eun-Hyung Lee 1 and Iñaki Sanz 1, 1Emory University, Atlanta, GA, 2Emory Univeristy, Atlanta, 3Emory University, Atlanta

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: SLE and ASC

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a severe systemic autoimmune disease in which multiple autoantibodies against nuclear, cytoplasmic and cell surface auto-antigens are produced by antibody secreting cells (ASCs). In the non-disease state, the frequency of circulating ASCs in total B cells is extremely low, and increases in a tightly regulated manner following immunization or infection. However, during active SLE, ASCs are dysregulated and exhibit a dramatic increase in the circulation. Indeed, the frequency of ASCs in the peripheral blood is correlated with disease activity, as measured by the SLEDAI scoring system. Despite their clinical significance, the subsets, morphology, and molecular phenotypes of circulating ASCs in SLE remain largely unknown.

Methods: Healthy subjects received the vaccination against influenza virus were recruited and peripheral blood from healthy controls was obtained at the steady state or at the peak of antibody secreting response after vaccination (day 6-7). Patients with SLE fulfilled four or more criteria of the modified American College of Rheumatology classification were recruited and evaluated by expert rheumatologists for disease status.

Results: In this study, peripheral ASC were divided into 4 subsets based on the surface expression of the CD19 and CD138: CD19+CD138- (pop2), CD19+CD138+ (pop3), CD19-CD138- (pop4), and CD19-CD138+ (pop5). CD19+ subsets, and to a larger extent, CD19- subsets, were markedly increased in active SLE patients compared to healthy controls post flu-vaccination. Besides, electron microscopy showed ultrastructural changes in the circulating ASCs subsets from active SLE patients relative to those from vaccinated healthy controls, including a condensed nucleus, enhanced endoplasmic reticulum volume, increased numbers of mitochondria, and presence of autophagosomes, features resembling those of bone marrow plasma cells. Interestingly, phenotypic characterization of circulating ASCs suggested that those from active SLE patients had significantly elevated expression of CXCR4, receptors for homing and survival in the bone marrow, compared to healthy controls post vaccination. Furthermore, next generation sequencing was used to analyze the clonality and connectivity between circulating ASC subsets from active SLE patients. In most flare SLE patients, we observed highly polyclonal repertoire and clonal relatedness in all ASC subsets.

Conclusion: Together, these data show that, during flare SLE, ASCs dramatically increase and undergo morphological changes and CXCR4 upregulation, indicating their potential of bone marrow homing and becoming long-lived plasma cells.

Rise of the circulating antibody-secreting cells in SLE patients during flare.

All ASC subsets are markedly increased in flaring SLE patients.

Ultra structural morphology of ASC subsets from SLE patients and healthy subjects.


Disclosure: W. Chen, None; S. Hong, None; C. Tipton, None; J. Hom, None; F. Anam, None; E. Lee, None; I. Sanz, None.

To cite this abstract in AMA style:

Chen W, Hong S, Tipton C, Hom J, Anam F, Lee E, Sanz I. Characterization of Antibody Secreting Cells in Patients with Active Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/characterization-of-antibody-secreting-cells-in-patients-with-active-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-antibody-secreting-cells-in-patients-with-active-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology